{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:13:23Z","timestamp":1790417603014,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870833"],"award-info":[{"award-number":["81870833"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ischemic events are the most common postoperative complication in bypass surgery for moyamoya disease (MMD), but the risk factors for pediatric MMD remain unclear. The goal of the study was to investigate the risk factors for postoperative ischemic complications in pediatric MMD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed a consecutive series of pediatric MMD cases at Beijing Tiantan Hospital, Capital Medical University from June 2010 through June 2019. Preoperative clinical variables and radiographic findings were recorded, and logistic regression analysis was carried out to identify the risk factors for postoperative ischemic events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 533 operations in 336 patients were included in this study. Postoperative complications occurred after 51 operations (9.6%), including 40\/447 indirect bypass procedures, 9\/70 direct bypass procedures, and 2\/16 combined bypass procedures. Postoperative ischemic events were the most common complication and occurred in 30 patients after 31 procedures (8.9% per patient; 5.8% per operation), including 26\/447 indirect bypass procedures, 4\/70 direct bypass procedures, and 1\/16 combined bypass procedures, and the incidence of these events did not differ significantly between indirect and non-indirect bypass (5.8% vs 5.8%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.999). Multivariate logistic regression analyses revealed that older age at operation (OR 1.129, 95% CI 1.011\u20131.260,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.032) and posterior cerebral artery involvement (OR 2.587, 95% CI 1.030\u20136.496,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043) were significantly associated with postoperative ischemic events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We speculate that older age at operation and posterior cerebral artery involvement are risk factors for postoperative ischemic events in pediatric MMD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-021-02283-9","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T09:12:39Z","timestamp":1624612359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Risk factors for postoperative ischemic complications in pediatric moyamoya disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiaofeng","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peicong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-4484","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"12","key":"2283_CR1","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226\u201337.","journal-title":"N Engl J Med"},{"issue":"3","key":"2283_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288\u201399.","journal-title":"Arch Neurol"},{"issue":"1","key":"2283_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5853\/jos.2015.01627","volume":"18","author":"JS Kim","year":"2016","unstructured":"Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18(1):2\u201311.","journal-title":"J Stroke"},{"issue":"1","key":"2283_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2015.01739","volume":"18","author":"T Kim","year":"2016","unstructured":"Kim T, Oh CW, Bang JS, Kim JE, Cho WS. Moyamoya disease: treatment and outcomes. J Stroke. 2016;18(1):21\u201330.","journal-title":"J Stroke"},{"issue":"1","key":"2283_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ana.21981","volume":"68","author":"SK Kim","year":"2010","unstructured":"Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC. Pediatric moyamoya disease: an analysis of 410 consecutive cases. Ann Neurol. 2010;68(1):92\u2013101.","journal-title":"Ann Neurol"},{"issue":"2","key":"2283_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000369524","volume":"39","author":"XY Bao","year":"2015","unstructured":"Bao XY, Duan L, Yang WZ, Li DS, Sun WJ, Zhang ZS, Zong R, Han C. Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China. Cerebrovasc Dis. 2015;39(2):75\u201381.","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"2283_CR7","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1161\/STROKEAHA.119.025609","volume":"50","author":"EJ Ha","year":"2019","unstructured":"Ha EJ, Kim KH, Wang KC, Phi JH, Lee JY, Choi JW, Cho BK, Yang J, Byun YH, Kim SK. Long-Term outcomes of indirect bypass for 629 children with moyamoya disease: longitudinal and cross-sectional analysis. Stroke. 2019;50(11):3177\u201383.","journal-title":"Stroke"},{"key":"2283_CR8","doi-asserted-by":"crossref","unstructured":"Zhao M, Deng X, Zhang D, Wang S, Zhang Y, Wang R, Zhao J. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease. J Neurosurg. 2019;130:531\u201352.","DOI":"10.3171\/2017.10.JNS171749"},{"key":"2283_CR9","doi-asserted-by":"crossref","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52(5):245\u201366.","DOI":"10.2176\/nmc.52.245"},{"issue":"10","key":"2283_CR10","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1161\/STROKEAHA.119.024487","volume":"50","author":"ZW Liu","year":"2019","unstructured":"Liu ZW, Han C, Zhao F, Qiao PG, Wang H, Bao XY, Zhang ZS, Yang WZ, Li DS, Duan L. Collateral circulation in moyamoya disease: a new grading system. Stroke. 2019;50(10):2708\u201315.","journal-title":"Stroke"},{"issue":"5","key":"2283_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3171\/2016.12.JNS162626","volume":"128","author":"X Deng","year":"2018","unstructured":"Deng X, Gao F, Zhang D, Zhang Y, Wang R, Wang S, Cao Y, Zhao Y, Pan Y, Ye X, Liu X, Zhang Q, Wang J, Yang Z, Zhao M, Zhao J. Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study. J Neurosurg. 2018;128(5):1327\u201337.","journal-title":"J Neurosurg"},{"issue":"5","key":"2283_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000336765","volume":"33","author":"M Fujimura","year":"2012","unstructured":"Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis. 2012;33(5):436\u201345.","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"2283_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/02688697.2012.757294","volume":"27","author":"WG Zhao","year":"2013","unstructured":"Zhao WG, Luo Q, Jia JB, Yu JL. Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease. Br J Neurosurg. 2013;27(3):321\u20135.","journal-title":"Br J Neurosurg"},{"key":"2283_CR14","unstructured":"Ravindran K, Wellons JC, Dewan MC. Surgical outcomes for pediatric moyamoya: a systematic review and meta-analysis. J Neurosurg Pediatr. 2019:1\u201310."},{"key":"2283_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3389\/fneur.2019.00795","volume":"10","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Lu J, Yu S, Li J, Deng X, Zhang Y, Zhang D, Wang R, Wang H, Zhao Y. Comparison of long-term effect between direct and indirect bypass for pediatric ischemic-type moyamoya disease: a propensity score-matched study. Front Neurol. 2019;10:795.","journal-title":"Front Neurol"},{"issue":"4","key":"2283_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10143-016-0734-7","volume":"39","author":"S Rashad","year":"2016","unstructured":"Rashad S, Fujimura M, Niizuma K, Endo H, Tominaga T. Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management. Neurosurg Rev. 2016;39(4):615\u201323.","journal-title":"Neurosurg Rev"},{"key":"2283_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.wneu.2016.07.009","volume":"94","author":"H Kim","year":"2016","unstructured":"Kim H, Jang DK, Han YM, Sung JH, Park IS, Lee KS, Yang JH, Huh PW, Park YS, Kim DS, Han KD. Direct bypass versus indirect bypass in adult moyamoya angiopathy with symptoms or hemodynamic instability: a meta-analysis of comparative studies. World Neurosurg. 2016;94:273\u201384.","journal-title":"World Neurosurg"},{"issue":"4","key":"2283_CR18","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1227\/NEU.0b013e318208f1da","volume":"68","author":"M Fujimura","year":"2011","unstructured":"Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery. 2011;68(4):957\u201364. discussion 964\u2013965.","journal-title":"Neurosurgery"},{"issue":"5","key":"2283_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/bja\/aes470","volume":"110","author":"JW Hwang","year":"2013","unstructured":"Hwang JW, Yang HM, Lee H, Lee HK, Jeon YT, Kim JE, Lim YJ, Park HP. Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease. Br J Anaesth. 2013;110(5):773\u20139.","journal-title":"Br J Anaesth"},{"issue":"5 Suppl","key":"2283_CR20","first-page":"433","volume":"103","author":"SH Kim","year":"2005","unstructured":"Kim SH, Choi JU, Yang KH, Kim TG, Kim DS. Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg. 2005;103(5 Suppl):433\u20138.","journal-title":"J Neurosurg"},{"key":"2283_CR21","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1016\/j.wneu.2018.01.212","volume":"113","author":"S Muraoka","year":"2018","unstructured":"Muraoka S, Araki Y, Kondo G, Kurimoto M, Shiba Y, Uda K, Ota S, Okamoto S, Wakabayashi T. Postoperative cerebral infarction risk factors and postoperative management of pediatric patients with moyamoya disease. World Neurosurg. 2018;113:e190-190e199.","journal-title":"World Neurosurg"},{"issue":"1","key":"2283_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2016.7.PEDS16218","volume":"19","author":"HG Kim","year":"2017","unstructured":"Kim HG, Lee SK, Lee JD. Characteristics of infarction after encephaloduroarteriosynangiosis in young patients with moyamoya disease. J Neurosurg Pediatr. 2017;19(1):1\u20137.","journal-title":"J Neurosurg Pediatr"},{"issue":"3","key":"2283_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00381-014-2582-5","volume":"31","author":"G Baltsavias","year":"2015","unstructured":"Baltsavias G, Khan N, Valavanis A. The collateral circulation in pediatric moyamoya disease. Childs Nerv Syst. 2015;31(3):389\u201398.","journal-title":"Childs Nerv Syst"},{"issue":"6","key":"2283_CR24","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.12.047","volume":"27","author":"P Ge","year":"2018","unstructured":"Ge P, Zhang Q, Ye X, Wang S, Zhang D, Zhao J. Clinical features, surgical treatment, and long-term outcome in children with hemorrhagic moyamoya disease. J Stroke Cerebrovasc Dis. 2018;27(6):1517\u201323.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"2283_CR25","first-page":"525","volume":"47","author":"K Honjo","year":"2019","unstructured":"Honjo K, Osato T, Omori S, Muraki T, Ishikawa K, Okamura N, Nakamura H. Preventing crying after revascularization surgery in pediatric patients with moyamoya disease: sedation with dexmedetomidine. No Shinkei Geka. 2019;47(5):525\u201330.","journal-title":"No Shinkei Geka"},{"issue":"2","key":"2283_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/pan.13293","volume":"28","author":"JK Lee","year":"2018","unstructured":"Lee JK, Williams M, Reyes M, Ahn ES. Cerebrovascular blood pressure autoregulation monitoring and postoperative transient ischemic attack in pediatric moyamoya vasculopathy. Paediatr Anaesth. 2018;28(2):94\u2013102.","journal-title":"Paediatr Anaesth"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02283-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02283-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02283-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T03:32:10Z","timestamp":1625110330000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02283-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2283"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02283-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Beijing Tiantan Hospital Ethics Committee, Capital medical university (Ethics review number: KY2016-048\u201301). We received appropriate approval and consent to utilize the raw data for this study from Beijing Tiantan Hospital, Capital Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}